BioGX Launches European Subsidiary to Expand Operations into Europe

BIRMINGHAM, Ala., April 21, 2017 /PRNewswire/ -- BioGX, a developer and manufacturer of molecular diagnostics CE-IVD tests has announced the establishment of European operations based in Amsterdam, Netherlands.  BioGX EU operation is at the core of the company's growth strategy into the European market with a goal to place sales, supply and support resources closer to its European customers.  BioGX EU will provide direct support to customers in Europe, the Middle East and Africa (EMEA) through regional technical sales and field application resources.   

According to Shazi Iqbal, Ph.D., CEO of BioGX, "BioGX EU operations will enhance the customer experience and lower costs by eliminating the complexity and expense associated with an international supply chain.  BioGX is well positioned to offer its full range of products and services to customers throughout the EMEA region."

About BioGX
BioGX manufactures molecular diagnostic CE-IVD tests and provides partner-specified formulation and manufacturing services for custom molecular reagent components.  Operating in a cGMP compliant environment, BioGX has a decade of experience in applying its proprietary platform-agnostic reagent technology across a variety of real-time PCR and Next Generation Sequencing platforms.  The Sample-Ready™ technology is applied within clinical, food safety, pharma, and water quality analysis industries worldwide.  For its achievements in exporting goods and services around the world, BioGX was honored with the 2017 Alabama Governor's Trade Excellence Award.

SOURCE BioGX

Related Links

http://www.biogx.com